{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T10:37:16Z","timestamp":1778495836076,"version":"3.51.4"},"reference-count":76,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"vor","delay-in-days":731,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cysticfibrosisjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.jcf.2015.01.006","type":"journal-article","created":{"date-parts":[[2015,2,10]],"date-time":"2015-02-10T05:34:13Z","timestamp":1423546453000},"page":"169-177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Cystic fibrosis and the role of gastrointestinal outcome measures in the new era of therapeutic CFTR modulation"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0263-9791","authenticated-orcid":false,"given":"Frank A.J.A.","family":"Bodewes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henkjan J.","family":"Verkade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan A.J.M.","family":"Taminiau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Drucy","family":"Borowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Wilschanski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2015.01.006_bb0005","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2015.01.006_bb0010","author":"Vertex Pharmaceuticals Incorporated"},{"key":"10.1016\/j.jcf.2015.01.006_bb0015","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1136\/thoraxjnl-2012-202550","article-title":"Progress in cystic fibrosis and the CF Therapeutics Development Network","volume":"67","author":"Rowe","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2015.01.006_bb0020","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jpeds.2012.10.008","article-title":"Evolution of pancreatic function during the first year in infants with cystic fibrosis","volume":"162","author":"O'Sullivan","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2015.01.006_bb0025","doi-asserted-by":"crossref","first-page":"a009753","DOI":"10.1101\/cshperspect.a009753","article-title":"The cystic fibrosis intestine","volume":"3","author":"De Lisle","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jcf.2015.01.006_bb0030","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jcf.2008.10.004","article-title":"Mechanism of direct bicarbonate transport by the CFTR anion channel","volume":"8","author":"Tang","year":"2009","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2015.01.006_bb0035","doi-asserted-by":"crossref","first-page":"G480","DOI":"10.1152\/ajpgi.00035.2004","article-title":"Acidic duodenal pH alters gene expression in the cystic fibrosis mouse pancreas","volume":"287","author":"Kaur","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jcf.2015.01.006_bb0040","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00005176-199612000-00001","article-title":"Gastrointestinal pH, motility\/transit and permeability in cystic fibrosis","volume":"23","author":"Gregory","year":"1996","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2015.01.006_bb0045","first-page":"115","article-title":"In vitro comparison of physical parameters, enzyme activity, acid resistance, and pH dissolution characteristics of enteric-coated pancreatic enzyme preparations: implications for clinical variability and pharmacy substitution","volume":"12","author":"Kuhn","year":"2007","journal-title":"J Pediatr Pharmacol Ther"},{"key":"10.1016\/j.jcf.2015.01.006_bb0050","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00005176-198811001-00002","article-title":"Digestive and absorptive phase anomalies associated with the exocrine pancreatic insufficiency of cystic fibrosis","volume":"7","author":"Roy","year":"1988","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2015.01.006_bb0055","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1074\/jbc.M110.136382","article-title":"Pancreatic bicarbonate secretion involves two proton pumps","volume":"286","author":"Novak","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcf.2015.01.006_bb0060","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1084\/jem.20120562","article-title":"Bicarbonate and functional CFTR channel are required for proper mucin secretion and link cystic fibrosis with its mucus phenotype","volume":"209","author":"Gustafsson","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.jcf.2015.01.006_bb0065","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0140-6736(08)61162-9","article-title":"Cystic fibrosis: impaired bicarbonate secretion and mucoviscidosis","volume":"372","author":"Quinton","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jcf.2015.01.006_bb0070","article-title":"Intestinal pH and Gastrointestinal Transit Profiles in Cystic Fibrosis Patients Measured by Wireless Motility Capsule","volume":"1\u20137","author":"Gelfond","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jcf.2015.01.006_bb0075","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1164\/rccm.201404-0703OC","article-title":"Clinical Mechanism of the Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor in G551D-mediated Cystic Fibrosis","volume":"190","author":"Rowe","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2015.01.006_bb0080","article-title":"Gastrointestinal transit times and motility in patients with cystic fibrosis","volume":"1\u20137","author":"Hedsund","year":"2012","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jcf.2015.01.006_bb0085","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/MPG.0b013e318290d112","article-title":"Delayed small bowel transit in children with cystic fibrosis and pancreatic insufficiency","volume":"57","author":"Rovner","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2015.01.006_bb0090","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jcf.2013.05.011","article-title":"Maximal daily dose of pancreatic enzyme replacement therapy in infants with cystic fibrosis: A reconsideration","volume":"12","author":"Borowitz","year":"2013","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2015.01.006_bb0095","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/adc.65.6.585","article-title":"Small intestinal permeability and orocaecal transit time in cystic fibrosis","volume":"65","author":"Dalzell","year":"1990","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jcf.2015.01.006_bb0100","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/bmj.287.6398.1011","article-title":"Prolonged small-intestinal transit time in cystic fibrosis","volume":"287","author":"Bali","year":"1983","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.jcf.2015.01.006_bb0105","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bpg.2009.02.014","article-title":"Methods and functions: Breath tests","volume":"23","author":"Braden","year":"2009","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jcf.2015.01.006_bb0110","first-page":"1236","article-title":"Procedure guideline for gastric emptying and motility. Society of Nuclear Medicine","volume":"40","author":"Donohoe","year":"1999","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jcf.2015.01.006_bb0115","first-page":"938","article-title":"Scintigraphic evaluation of small bowel transit in healthy subjects: inter- and intrasubject variability","volume":"90","author":"Argenyi","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jcf.2015.01.006_bb0120","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0016-5085(86)90631-1","article-title":"Impaired transit of chyme in chronic intestinal pseudoobstruction. Correction by cisapride","volume":"91","author":"Camilleri","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcf.2015.01.006_bb0125","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0016-5085(00)70251-4","article-title":"Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome","volume":"118","author":"Prather","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcf.2015.01.006_bb0130","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1007\/s10620-009-0899-9","article-title":"Wireless capsule motility: comparison of the SmartPill\u00ae GI monitoring system with scintigraphy for measuring whole gut transit","volume":"54","author":"Maqbool","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jcf.2015.01.006_bb0135","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.cgh.2009.01.017","article-title":"Investigation of colonic and whole-gut transit with wireless motility capsule and radiopaque markers in constipation","volume":"7","author":"Rao","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jcf.2015.01.006_bb0140","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s10620-012-2209-1","article-title":"Intestinal pH and gastrointestinal transit profiles in cystic fibrosis patients measured by wireless motility capsule","volume":"58","author":"Gelfond","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jcf.2015.01.006_bb0145","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-8278(96)80326-6","article-title":"Bile acid kinetics and biliary lipid composition in cystic fibrosis","volume":"25","author":"Strandvik","year":"1996","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcf.2015.01.006_bb0150","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0022-2143(03)00040-4","article-title":"Accurate enzymatic measurement of fecal bile acids in patients with malabsorption","volume":"141","author":"Porter","year":"2003","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jcf.2015.01.006_bb0155","first-page":"126","article-title":"Enterohepatic circulation in man of a gamma-emitting bile-acid conjugate, 23-selena-25-homotaurocholic acid (SeHCAT)","volume":"23","author":"Merrick","year":"1982","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jcf.2015.01.006_bb0160","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/gut.34.8.1137","article-title":"Intestinal bile acid malabsorption in cystic fibrosis","volume":"34","author":"O'Brien","year":"1993","journal-title":"Gut"},{"key":"10.1016\/j.jcf.2015.01.006_bb0165","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/0014-5793(91)80688-Y","article-title":"The plasma level of 7\u03b1-hydroxy-4-cholesten-3-one reflects the activity of hepatic cholesterol 7\u03b1-hydroxylase in man","volume":"284","author":"Axelson","year":"1991","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jcf.2015.01.006_bb0170","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/hep.22771","article-title":"High expression of the bile salt\u2010homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis","volume":"49","author":"Schaap","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jcf.2015.01.006_bb0175","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.crohns.2014.02.027","article-title":"Bile acid malabsorption assessed by 7 alpha-hydroxy-4-cholesten-3-one in pediatric inflammatory bowel disease: Correlation to clinical and laboratory findings","author":"Gothe","year":"2014","journal-title":"J Crohn's Colitis"},{"key":"10.1016\/j.jcf.2015.01.006_bb0180","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1155\/2011\/701287","article-title":"An evaluation of the use of serum 7-alpha-hydroxycholestenone as a diagnostic test of bile acid malabsorption causing watery diarrhea","volume":"25","author":"Brydon","year":"2011","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.jcf.2015.01.006_bb0185","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.jpeds.2013.06.083","article-title":"Serum 7-alpha-hydroxy-4-cholesten-3-one as a marker for bile acid loss in children","volume":"163","author":"Freudenberg","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2015.01.006_bb0190","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/ajcn\/76.5.1111","article-title":"Oat bran stimulates bile acid synthesis within 8h as measured by 7alpha-hydroxy-4-cholesten-3-one","volume":"76","author":"Andersson","year":"2002","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jcf.2015.01.006_bb0195","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.cgh.2009.04.024","article-title":"A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis","volume":"7","author":"Walters","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jcf.2015.01.006_bb0200","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/apt.12466","article-title":"Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention","volume":"38","author":"Pattni","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jcf.2015.01.006_bb0205","doi-asserted-by":"crossref","first-page":"e67160","DOI":"10.1371\/journal.pone.0067160","article-title":"Association between serum atypical fibroblast growth factors 21 and 19 and pediatric nonalcoholic fatty liver disease","volume":"8","author":"Alisi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jcf.2015.01.006_bb0210","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.biocel.2014.02.005","article-title":"Cystic fibrosis: Evidence for gut inflammation","volume":"52","author":"Munck","year":"2014","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.jcf.2015.01.006_bb0215","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/01.MIB.0000442681.85545.31","article-title":"Clinical utility of fecal biomarkers for the diagnosis and management of inflammatory bowel disease","volume":"20","author":"Kopylov","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jcf.2015.01.006_bb0220","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/948367","article-title":"Update of faecal markers of inflammation in children with cystic fibrosis","author":"Lee","year":"2012","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jcf.2015.01.006_bb0225","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1572-0241.2007.01126.x","article-title":"Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy","volume":"102","author":"von Roon","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jcf.2015.01.006_bb0230","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3109\/00365521.2014.987809","article-title":"Fecal calprotectin in diagnosis and clinical assessment of inflammatory bowel disease","volume":"50","author":"Sipponen","year":"2014","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jcf.2015.01.006_bb0235","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1365-2036.2004.02174.x","article-title":"Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration","volume":"20","author":"Bruzzese","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jcf.2015.01.006_bb0240","article-title":"Small intestine bacterial overgrowth does not correspond to intestinal inflammation in cystic fibrosis","volume":"1\u20135","author":"Lisowska","year":"2010","journal-title":"Scand J Clin Lab Investig"},{"key":"10.1016\/j.jcf.2015.01.006_bb0245","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/MPG.0b013e3181d1b013","article-title":"Evidence of Intestinal Inflammation in Patients With Cystic Fibrosis","volume":"51","author":"Werlin","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2015.01.006_bb0250","doi-asserted-by":"crossref","first-page":"e87796","DOI":"10.1371\/journal.pone.0087796","article-title":"Disrupted Intestinal Microbiota and Intestinal Inflammation in Children with Cystic Fibrosis and Its Restoration with Lactobacillus GG: A Randomised Clinical Trial","volume":"9","author":"Bruzzese","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jcf.2015.01.006_bb0255","doi-asserted-by":"crossref","first-page":"c3369","DOI":"10.1136\/bmj.c3369","article-title":"Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis","volume":"341","author":"van Rheenen","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.jcf.2015.01.006_bb0260","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1203\/00006450-200003000-00010","article-title":"Evidence of chronic inflammation in morphologically normal small intestine of cystic fibrosis patients","volume":"47","author":"Raia","year":"2000","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jcf.2015.01.006_bb0265","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/ppul.22697","article-title":"The role of endoscopy and biopsy in the management of severe gastrointestinal disease in cystic fibrosis patients","volume":"48","author":"Shah","year":"2013","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2015.01.006_bb0270","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cgh.2010.10.019","article-title":"Diagnostic accuracy of capsule endoscopy for small bowel Crohn's disease is superior to that of MR enterography or CT enterography","volume":"9","author":"Jensen","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jcf.2015.01.006_bb0275","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/ibd.21220","article-title":"Video capsule endoscopy in inflammatory bowel disease: past, present, and future redux","volume":"16","author":"Swaminath","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jcf.2015.01.006_bb0280","first-page":"1834","article-title":"Fecal elastase test: evaluation of a new noninvasive pancreatic function test","volume":"90","author":"Dominguez-Munoz","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jcf.2015.01.006_bb0285","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1203\/00006450-198603000-00002","article-title":"Age-related alterations of immunoreactive pancreatic cationic trypsinogen in sera from cystic fibrosis patients with and without pancreatic insufficiency","volume":"20","author":"Durie","year":"1986","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jcf.2015.01.006_bb0290","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1440-1754.1968.tb01723.x","article-title":"Pancreozymin secretin test of exocrine pancreatic funtion in cystic fribrosis and the significance of the result for the pathogenesis of the disease","volume":"4","author":"Hadorn","year":"1968","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.jcf.2015.01.006_bb0295","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jcf.2006.01.005","article-title":"Fecal elastase-1: utility in pancreatic function in cystic fibrosis","volume":"5","author":"Daftary","year":"2006","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2015.01.006_bb0300","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1067\/mpd.2002.124829","article-title":"How useful is fecal pancreatic elastase 1 as a marker of exocrine pancreatic disease?","volume":"141","author":"Beharry","year":"2002","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2015.01.006_bb0305","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/gut.23.9.744","article-title":"Secretin pancreozymin stimulation test and confirmation of the diagnosis of cystic fibrosis","volume":"23","author":"Wong","year":"1982","journal-title":"Gut"},{"key":"10.1016\/j.jcf.2015.01.006_bb0310","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/archpedi.1938.01980140114013","article-title":"Cystic fibrosis of the pancreas and its relation to celiac diseasea clinical and pathologic study","volume":"56","author":"Andersen","year":"1938","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.jcf.2015.01.006_bb0315","first-page":"347","article-title":"Rapid method for the determination of fat in feces","volume":"31","author":"Van","year":"1949","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcf.2015.01.006_bb0320","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cca.2008.10.001","article-title":"Comparative analysis of fecal fat quantitation via nuclear magnetic resonance spectroscopy (< sup>1H NMR) and gravimetry","volume":"400","author":"Korpi-Steiner","year":"2009","journal-title":"Clin Chim Acta"},{"issue":"Suppl. 34","key":"10.1016\/j.jcf.2015.01.006_bb0325","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1177\/014107689809134S02","article-title":"Uses and abuses of enzyme therapy in cystic fibrosis","volume":"91","author":"Durie","year":"1998","journal-title":"J R Soc Med"},{"key":"10.1016\/j.jcf.2015.01.006_bb0330","doi-asserted-by":"crossref","first-page":"731","DOI":"10.4155\/cli.13.63","article-title":"Study design considerations for evaluating the efficacy and safety of pancreatic enzyme replacement therapy in patients with cystic fibrosis","volume":"3","author":"Konstan","year":"2013","journal-title":"Clin Invest"},{"key":"10.1016\/j.jcf.2015.01.006_bb0335","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/ajcn\/69.1.127","article-title":"Fat malabsorption in cystic fibrosis patients receiving enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids","volume":"69","author":"Kalivianakis","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jcf.2015.01.006_bb0340","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1203\/00006450-200201000-00011","article-title":"Functional development of fat absorption in term and preterm neonates strongly correlates with ability to absorb long-chain fatty acids from intestinal lumen","volume":"51","author":"Rings","year":"2002","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jcf.2015.01.006_bb0345","doi-asserted-by":"crossref","first-page":"263","DOI":"10.5414\/CP201793","article-title":"Diagnosing malabsorption with systemic lipid profiling: pharmacokinetics of pentadecanoic acid and triheptadecanoic acid following oral administration in healthy subjects and subjects with cystic fibrosis","volume":"51","author":"Stallings","year":"2013","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.jcf.2015.01.006_bb0350","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/ajcn\/72.1.174","article-title":"Detection of impaired intestinal absorption of long-chain fatty acids: validation studies of a novel test in a rat model of fat malabsorption","volume":"72","author":"Kalivianakis","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jcf.2015.01.006_bb0355","doi-asserted-by":"crossref","first-page":"e73905","DOI":"10.1371\/journal.pone.0073905","article-title":"Multicenter intestinal current measurements in rectal biopsies from CF and non-CF subjects to monitor CFTR function","volume":"8","author":"Clancy","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jcf.2015.01.006_bb0360","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/thx.2009.125088","article-title":"Intestinal current measurement for diagnostic classification of patients with questionable cystic fibrosis: validation and reference data","volume":"65","author":"Derichs","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2015.01.006_bb0365","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1183\/09031936.00057512","article-title":"CFTR biomarkers: time for promotion to surrogate end-point","volume":"41","author":"De Boeck","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2015.01.006_bb0370","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ppul.22586","article-title":"Evaluation of the intestinal current measurement method as a diagnostic test for cystic fibrosis","volume":"48","author":"Cohen\u2010Cymberknoh","year":"2013","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2015.01.006_bb0375","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nm.3201","article-title":"A functional CFTR assay using primary cystic fibrosis intestinal organoids","volume":"19","author":"Dekkers","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.jcf.2015.01.006_bb0380","doi-asserted-by":"crossref","first-page":"e27112","DOI":"10.4161\/rdis.27112","article-title":"Novel opportunities for CFTR-targeting drug development using organoids","volume":"1","author":"Dekkers","year":"2013","journal-title":"Rare Dis"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199315000089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199315000089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T04:15:09Z","timestamp":1651205709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199315000089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":76,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1569199315000089"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2015.01.006","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cystic fibrosis and the role of gastrointestinal outcome measures in the new era of therapeutic CFTR modulation","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2015.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}